FDA recall D-1332-2022

SterRx, LLC · Class II · drug

Product

fentaNYL Citrate in 0.9% Sodium Chloride, 2.5 mg per 250 mL, (10 mcg per mL) IV bags, Rx Only, SterRx, 141 Idaho Avenue, Plattsburgh, NY 12903, NDC 70324-327-02.

Reason for recall

Lack of Assurance of Sterility

Distribution

Nationwide within the United States

Key facts

Status
Terminated
Initiation date
2022-07-25
Report date
2022-08-17
Termination date
2023-06-22
Voluntary/Mandated
Voluntary: Firm initiated
Location
Plattsburgh, NY, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1332-2022